Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression

NCT00517387 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00517387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00517387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
September 30, 2010
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unipolar depression